Holocene Advisors’s Avanos Medical AVNS Stock Holding History

Holocene Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-8,225	Closed	-$225K	–	803
2022 Q2	$225K	Sell	8,225 -29,584	-78%	-$850K	﹤0.01%	777
2022 Q1	$1.27M	Sell	37,809 -7,661	-17%	-$247K	0.01%	649
2021 Q4	$1.58M	Buy	45,470 +5,967	+15%	+$193K	0.01%	603
2021 Q3	$1.23M	Buy	+39,503	New	+$1.34M	0.01%	635
2020 Q4	–	Sell	-7,024	Closed	-$233K	–	738
2020 Q3	$233K	Buy	+7,024	New	+$224K	﹤0.01%	634
2020 Q2	–	Sell	-36,271	Closed	-$977K	–	612
2020 Q1	$977K	Sell	36,271 -4,707	-11%	-$141K	0.01%	437
2019 Q4	$1.38M	Sell	40,978 -5,874	-13%	-$213K	0.01%	494
2019 Q3	$1.75M	Buy	46,852 +30,596	+188%	+$1.17M	0.02%	342
2019 Q2	$709K	Buy	16,256 +3,348	+26%	+$143K	0.01%	374
2019 Q1	$551K	Sell	12,908 -12,220	-49%	-$547K	0.01%	391
2018 Q4	$1.13M	Buy	+25,128	New	+$1.32M	0.02%	246

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Holocene Advisors's AVNS Position: Q3 2022 in Review

Holocene Advisors sold out of Avanos Medical (AVNS) in Q3 2022, closing a stake of 8,225 shares — an estimated $225K sold.

Holocene Advisors first reported a position in AVNS in Q4 2018 and held it in 11 quarters. The position peaked at $1.75M in Q3 2019. 274 funds tracked by Wall St. Rank hold AVNS as of Q3 2022.

Holocene Advisors reported no remaining Avanos Medical position as of Q3 2022 after selling out during the quarter.
Holocene Advisors sold 8,225 Avanos Medical shares in Q3 2022, an estimated $225K.
Holocene Advisors first reported a position in Avanos Medical in Q4 2018 and held it in 11 quarters.
Holocene Advisors's Avanos Medical position peaked at $1.75M in Q3 2019.
274 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2022.

Based on Holocene Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.